Itama Ranoraya (IRRA) - Total Liabilities
Based on the latest financial reports, Itama Ranoraya (IRRA) has total liabilities worth Rp2.16 Trillion IDR (≈ $126.85 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Itama Ranoraya to assess how effectively this company generates cash.
Itama Ranoraya - Total Liabilities Trend (2016–2024)
This chart illustrates how Itama Ranoraya's total liabilities have evolved over time, based on quarterly financial data. Check IRRA financial resilience to evaluate the company's liquid asset resilience ratio.
Itama Ranoraya Competitors by Total Liabilities
The table below lists competitors of Itama Ranoraya ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Yuhwa Securities Co Ltd
KO:003465
|
Korea | ₩217.69 Billion |
|
Cypherpunk Technologies Inc.
NASDAQ:CYPH
|
USA | $52.61 Million |
|
Mobileleader Co.Ltd
KQ:100030
|
Korea | ₩13.06 Billion |
|
BG T&A Co
KQ:046310
|
Korea | ₩27.01 Billion |
|
Accentis
BR:ACCB
|
Belgium | €18.28 Million |
|
KebNi AB (publ)
ST:KEBNI-B
|
Sweden | Skr37.29 Million |
|
BRIDGETEC Corp
KQ:064480
|
Korea | ₩13.88 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Itama Ranoraya's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IRRA stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.80 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Itama Ranoraya's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Itama Ranoraya (2016–2024)
The table below shows the annual total liabilities of Itama Ranoraya from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp1.15 Trillion ≈ $67.19 Million |
+91.21% |
| 2023-12-31 | Rp599.69 Billion ≈ $35.14 Million |
+139.99% |
| 2022-12-31 | Rp249.88 Billion ≈ $14.64 Million |
-10.75% |
| 2021-12-31 | Rp279.99 Billion ≈ $16.41 Million |
-4.42% |
| 2020-12-31 | Rp292.94 Billion ≈ $17.17 Million |
+224.54% |
| 2019-12-31 | Rp90.26 Billion ≈ $5.29 Million |
+29.66% |
| 2018-12-31 | Rp69.62 Billion ≈ $4.08 Million |
-16.45% |
| 2017-12-31 | Rp83.32 Billion ≈ $4.88 Million |
+407.44% |
| 2016-12-31 | Rp16.42 Billion ≈ $962.18K |
-- |
About Itama Ranoraya
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more